Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Keating

Showing results (701-710 of 1,289) with videos related to

Pageof 129
Sort By:
Blood Cells|January 1, 1983
Quantitative cytology in leukemia researchB Barlogie, A M Maddox, D A Johnston, et al.
Haematology and Blood Transfusion|January 1, 1990
Treatment of poor-prognosis, newly diagnosed acute myelogenous leukemia with high-dose cytosine arabinoside (Ara-C) and rHUGM-CSFE H Estey, H M Kantarjian, M Beran, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 15, 2011
Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphomaYi Zhou, Guilin Tang, L Jeffrey Medeiros, et al.
American Journal of Hematology|March 1, 1997
Expression profile of MDM-2 proteins in chronic lymphocytic leukemia and their clinical relevanceM A Haidar, H El-Hajj, C E Bueso-Ramos, et al.
Cancer|January 28, 1999
Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literatureA Aguayo, J E Cortes, H M Kantarjian, et al.
Southern Medical Journal|October 1, 1987
Old age: a sign of poor prognosis in patients with chronic myelogenous leukemiaH M Kantarjian, M J Keating, K B McCredie, et al.
Australian and New Zealand Journal of Medicine|June 1, 1982
Retrospective analysis of 158 cases of adult acute leukaemia: factors influencing prognosis and treatment responseE Januszewicz, F C Firkin, C N Chesterman, et al.
Cancer|April 1, 1988
Characteristics of accelerated disease in chronic myelogenous leukemiaH M Kantarjian, D Dixon, M J Keating, et al.
The Journal of Biological Chemistry|July 29, 2011
Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysisYunfei Zhou, Yan Zhou, Takashi Shingu, et al.
Journal of Bacteriology|August 1, 1991
Characterization and expression of the Escherichia coli Mrr restriction systemP A Waite-Rees, C J Keating, L S Moran, et al.
Pageof 129

Showing results (701-710 of 1,289) with videos related to

Sort By:
Pageof 129
Blood Cells|January 1, 1983
Quantitative cytology in leukemia researchB Barlogie, A M Maddox, D A Johnston, et al.
Haematology and Blood Transfusion|January 1, 1990
Treatment of poor-prognosis, newly diagnosed acute myelogenous leukemia with high-dose cytosine arabinoside (Ara-C) and rHUGM-CSFE H Estey, H M Kantarjian, M Beran, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 15, 2011
Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphomaYi Zhou, Guilin Tang, L Jeffrey Medeiros, et al.
American Journal of Hematology|March 1, 1997
Expression profile of MDM-2 proteins in chronic lymphocytic leukemia and their clinical relevanceM A Haidar, H El-Hajj, C E Bueso-Ramos, et al.
Cancer|January 28, 1999
Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literatureA Aguayo, J E Cortes, H M Kantarjian, et al.
Southern Medical Journal|October 1, 1987
Old age: a sign of poor prognosis in patients with chronic myelogenous leukemiaH M Kantarjian, M J Keating, K B McCredie, et al.
Australian and New Zealand Journal of Medicine|June 1, 1982
Retrospective analysis of 158 cases of adult acute leukaemia: factors influencing prognosis and treatment responseE Januszewicz, F C Firkin, C N Chesterman, et al.
Cancer|April 1, 1988
Characteristics of accelerated disease in chronic myelogenous leukemiaH M Kantarjian, D Dixon, M J Keating, et al.
The Journal of Biological Chemistry|July 29, 2011
Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysisYunfei Zhou, Yan Zhou, Takashi Shingu, et al.
Journal of Bacteriology|August 1, 1991
Characterization and expression of the Escherichia coli Mrr restriction systemP A Waite-Rees, C J Keating, L S Moran, et al.
Pageof 129